Sinusitis & rhinitis — all decisions

The Board granted service connection for allergic rhinitis and generalized anxiety disorder, and increased the rating for migraine headaches to 50%. The appeal for bilateral hearing loss was dismissed.

The Board granted service connection for right shoulder arthritis and denied service connection for bilateral hearing loss. The remaining claims were remanded to correct a pre-decisional duty to assist error.

The Board denied service connection for a left meniscus tear, right knee instability, chronic sinusitis or other condition of the nose, throat, larynx and pharynx, diabetes, type 1 or type 2, hypertension (high blood pressure), tinnitus, and visual impairment, including blurry vision, blindness and double vision.

The Board denied service connection for sinusitis, mixed sleep apnea, and tinnitus as there was no evidence of a current disability or an in-service event, injury, or disease related to these conditions.

The Board granted an effective date of December 8, 2017, for the grant of service connection for rhinitis but denied initial compensable ratings and higher ratings for other conditions.

The appeal for service connection for a pulmonary condition other than allergic rhinitis was dismissed, while the effective date of service connection for allergic rhinitis was granted earlier to July 14, 2017. The claim for an initial compensable rating for allergic rhinitis was remanded.

The Board denied service connection for sinusitis, bronchitis, liver abscess, abdominal aorta, left and right hamstring disabilities. The Board granted an increased disability rating of 40 percent for right upper extremity radiculopathy but denied all other claims.

The Board granted service connection for irritable bowel syndrome and sinus problems, diagnosed as chronic sinusitis and allergic rhinitis.

The Board granted service connection for non-allergic rhinitis, chronic sinusitis, and macular degeneration based on the evidence of record.

The Board denied the Veteran's appeal for an earlier effective date for a TDIU and remanded several service connection claims.

The Board denied service connection for allergic rhinitis and chronic fatigue syndrome, denied an initial compensable rating for bilateral hearing loss disability, denied increased ratings in excess of 30 percent for chronic sinusitis, granted a 50 percent initial rating for tension headaches, and denied initial compensable ratings for dermatitis and respiratory disability (shortness of breath).

The Board granted service connection for chronic sinusitis and a lumbar spine disorder, diagnosed as lumbar spinal stenosis.

The Board denied the Veteran's claim for a compensable rating for allergic rhinitis as there was no evidence of greater than 50 percent obstruction of the nasal passage on both sides, complete obstruction on one side, or nasal polyps.

The Board denied service connection for asthma, chronic sinusitis, chronic rhinitis, and chronic bronchitis as there was no evidence of current diagnoses at any time since or proximate to when the Veteran filed the claim.

The Board dismissed the appeal for service connection for sinusitis, nose irritation, itching, nose bleeds and sleep difficulties/snoring due to a concurrent election of administrative review options which is prohibited.

The Board denied an increased rating for sinusitis and a compensable rating for rhinitis but granted a 30% rating for migraines from May 9, 2023, to May 18, 2024, and a 50% rating for migraines starting May 19, 2024.

The Board denied an increased rating for allergic rhinitis but granted service connection for sinusitis on a presumptive basis due to exposure to fine, particulate matter during the Persian Gulf War.

The Board remands the claims for an initial rating in excess of 0 percent for chronic sinusitis and allergic rhinitis due to insufficient evidence.

The appeal for a rating in excess of 10 percent for allergic rhinitis was dismissed as moot, and the appeal for a rating in excess of 30 percent for chronic sinusitis was denied.

The Board granted a 20 percent rating for IBS from May 19, 2024, and denied higher ratings or initial ratings in excess of 10 percent for chronic sinusitis and allergic rhinitis.